NCT07078799 Wavefront-guided LASIK Surgery Compared to Ray Tracing-Guided LASIK Surgery
| NCT ID | NCT07078799 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Stanford University |
| Condition | Myopia |
| Study Type | INTERVENTIONAL |
| Enrollment | 70 participants |
| Start Date | 2026-01-20 |
| Primary Completion | 2027-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 70 participants in total. It began in 2026-01-20 with a primary completion date of 2027-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
We are enrolling participants aged 22 and older to have LASIK surgery in both eyes. We will perform wavefront-guided LASIK in one eye and ray tracing-guided LASIK in the fellow eye of each participant. We are trying to see if there are any differences in the efficacy between the two types of LASIK procedures.
Eligibility Criteria
Inclusion Criteria: 1. Age 22 and older 2. People with healthy eyes: 1. No abnormal corneal shape 2. No excessively thin corneas 3. No eye diseases such as glaucoma or cataracts 3. Nearsightedness between -1.00 diopters and -10.00 diopters. 4. Subjects with less than or equal to 3.00 diopters of astigmatism. 5. Subjects must have similar levels of nearsightedness in each eye. Exclusion Criteria: 1. Subjects under the age of 22. 2. Subjects with excessively thin corneas. 3. Subjects with topographic evidence of keratoconus. 4. Subjects with ectactic eye disorders. 5. Subjects with autoimmune diseases. 6. Subjects who are pregnant or nursing at the time of surgery. (The FDA-approved labelling indications for LASIK specifically excludes patients who are pregnant or nursing. There is no strict prohibition not to become pregnant during the one year study period) 7. They can not be more than 1.5 diopter of difference between eyes. 8. Subjects with more than 3.00 diopters of astigmatism 9. Subjects with disimilar levels of astigmatism in each eye (They can not have more than 0.75 diopters of difference between eyes) -
Contact & Investigator
Edward E Manche, MD
PRINCIPAL INVESTIGATOR
Stanford University
Frequently Asked Questions
Who can join the NCT07078799 clinical trial?
This trial is open to participants of all sexes, aged 22 Years or older, up to 59 Years, studying Myopia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07078799 currently recruiting?
Yes, NCT07078799 is actively recruiting participants. Contact the research team at cornea@stanford.edu for enrollment information.
Where is the NCT07078799 trial being conducted?
This trial is being conducted at Palo Alto, United States.
Who is sponsoring the NCT07078799 clinical trial?
NCT07078799 is sponsored by Stanford University. The principal investigator is Edward E Manche, MD at Stanford University. The trial plans to enroll 70 participants.